A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer

Laila S. Tabatabai, Joan Bloom, Susan L Stewart, Deborah E. Sellmeyer

Research output: Contribution to journalArticle

Abstract

Background/Introduction/Objective: Premenopausal women treated for breast cancer are at high risk for bone loss. This trial examined the effects of a 1-year combined aerobic and resistance exercise program on bone mineral density (BMD) in women treated for premenopausal breast cancer. Materials and Methods: Premenopausal women (n = 206) age ≤ 55 years at cancer diagnosis who were within two years of receiving adjuvant chemotherapy were randomized to a 12-month exercise program or a control group. BMD was measured by dual-energy X-ray absorptiometry at baseline and after 1 year; blood was drawn for skeletal markers. Change from baseline to end of study was compared within and between treatment groups using paired and unpaired t-tests. Results: Lumbar spine BMD declined in both treatment groups with no significant difference between treatment groups (-0.008 ± 0.003 g/cm2 exercise vs. -0.014 ± 0.003 g/cm2 control, p = 0.24). However, among the women who did not lose lean mass during the study (n = 100, 54 control, 46 exercise), the exercise intervention prevented lumbar spine bone loss (0.001 ± 0.005 g/cm2 treatment group vs. -0.014 ± 0.005 g/cm2 control group, p = 0.03). Bone turnover markers decreased significantly in both groups with no differences between groups. Conclusions: Among women who maintained lean mass, our exercise intervention prevented bone loss; however, our intervention did not prevent bone loss among women who lost muscle mass. Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment.

LanguageEnglish (US)
Pages87-92
Number of pages6
JournalJournal of Women's Health
Volume28
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Randomized Controlled Trials
Exercise
Breast Neoplasms
Bone and Bones
Bone Density
Spine
Therapeutics
Muscles
Control Groups
Bone Remodeling
Photon Absorptiometry
Adjuvant Chemotherapy
Neoplasms

Keywords

  • Bone density
  • Bone loss
  • Breast cancer
  • Exercise
  • Osteoporosis
  • Premenopausal

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer. / Tabatabai, Laila S.; Bloom, Joan; Stewart, Susan L; Sellmeyer, Deborah E.

In: Journal of Women's Health, Vol. 28, No. 1, 01.01.2019, p. 87-92.

Research output: Contribution to journalArticle

Tabatabai, Laila S. ; Bloom, Joan ; Stewart, Susan L ; Sellmeyer, Deborah E. / A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer. In: Journal of Women's Health. 2019 ; Vol. 28, No. 1. pp. 87-92.
@article{43e2c15b64bd47d391abe0461ab75fb5,
title = "A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer",
abstract = "Background/Introduction/Objective: Premenopausal women treated for breast cancer are at high risk for bone loss. This trial examined the effects of a 1-year combined aerobic and resistance exercise program on bone mineral density (BMD) in women treated for premenopausal breast cancer. Materials and Methods: Premenopausal women (n = 206) age ≤ 55 years at cancer diagnosis who were within two years of receiving adjuvant chemotherapy were randomized to a 12-month exercise program or a control group. BMD was measured by dual-energy X-ray absorptiometry at baseline and after 1 year; blood was drawn for skeletal markers. Change from baseline to end of study was compared within and between treatment groups using paired and unpaired t-tests. Results: Lumbar spine BMD declined in both treatment groups with no significant difference between treatment groups (-0.008 ± 0.003 g/cm2 exercise vs. -0.014 ± 0.003 g/cm2 control, p = 0.24). However, among the women who did not lose lean mass during the study (n = 100, 54 control, 46 exercise), the exercise intervention prevented lumbar spine bone loss (0.001 ± 0.005 g/cm2 treatment group vs. -0.014 ± 0.005 g/cm2 control group, p = 0.03). Bone turnover markers decreased significantly in both groups with no differences between groups. Conclusions: Among women who maintained lean mass, our exercise intervention prevented bone loss; however, our intervention did not prevent bone loss among women who lost muscle mass. Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment.",
keywords = "Bone density, Bone loss, Breast cancer, Exercise, Osteoporosis, Premenopausal",
author = "Tabatabai, {Laila S.} and Joan Bloom and Stewart, {Susan L} and Sellmeyer, {Deborah E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1089/jwh.2017.6863",
language = "English (US)",
volume = "28",
pages = "87--92",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer

AU - Tabatabai, Laila S.

AU - Bloom, Joan

AU - Stewart, Susan L

AU - Sellmeyer, Deborah E.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background/Introduction/Objective: Premenopausal women treated for breast cancer are at high risk for bone loss. This trial examined the effects of a 1-year combined aerobic and resistance exercise program on bone mineral density (BMD) in women treated for premenopausal breast cancer. Materials and Methods: Premenopausal women (n = 206) age ≤ 55 years at cancer diagnosis who were within two years of receiving adjuvant chemotherapy were randomized to a 12-month exercise program or a control group. BMD was measured by dual-energy X-ray absorptiometry at baseline and after 1 year; blood was drawn for skeletal markers. Change from baseline to end of study was compared within and between treatment groups using paired and unpaired t-tests. Results: Lumbar spine BMD declined in both treatment groups with no significant difference between treatment groups (-0.008 ± 0.003 g/cm2 exercise vs. -0.014 ± 0.003 g/cm2 control, p = 0.24). However, among the women who did not lose lean mass during the study (n = 100, 54 control, 46 exercise), the exercise intervention prevented lumbar spine bone loss (0.001 ± 0.005 g/cm2 treatment group vs. -0.014 ± 0.005 g/cm2 control group, p = 0.03). Bone turnover markers decreased significantly in both groups with no differences between groups. Conclusions: Among women who maintained lean mass, our exercise intervention prevented bone loss; however, our intervention did not prevent bone loss among women who lost muscle mass. Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment.

AB - Background/Introduction/Objective: Premenopausal women treated for breast cancer are at high risk for bone loss. This trial examined the effects of a 1-year combined aerobic and resistance exercise program on bone mineral density (BMD) in women treated for premenopausal breast cancer. Materials and Methods: Premenopausal women (n = 206) age ≤ 55 years at cancer diagnosis who were within two years of receiving adjuvant chemotherapy were randomized to a 12-month exercise program or a control group. BMD was measured by dual-energy X-ray absorptiometry at baseline and after 1 year; blood was drawn for skeletal markers. Change from baseline to end of study was compared within and between treatment groups using paired and unpaired t-tests. Results: Lumbar spine BMD declined in both treatment groups with no significant difference between treatment groups (-0.008 ± 0.003 g/cm2 exercise vs. -0.014 ± 0.003 g/cm2 control, p = 0.24). However, among the women who did not lose lean mass during the study (n = 100, 54 control, 46 exercise), the exercise intervention prevented lumbar spine bone loss (0.001 ± 0.005 g/cm2 treatment group vs. -0.014 ± 0.005 g/cm2 control group, p = 0.03). Bone turnover markers decreased significantly in both groups with no differences between groups. Conclusions: Among women who maintained lean mass, our exercise intervention prevented bone loss; however, our intervention did not prevent bone loss among women who lost muscle mass. Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment.

KW - Bone density

KW - Bone loss

KW - Breast cancer

KW - Exercise

KW - Osteoporosis

KW - Premenopausal

UR - http://www.scopus.com/inward/record.url?scp=85059828302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059828302&partnerID=8YFLogxK

U2 - 10.1089/jwh.2017.6863

DO - 10.1089/jwh.2017.6863

M3 - Article

VL - 28

SP - 87

EP - 92

JO - Journal of Women's Health

T2 - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 1

ER -